Relationships between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with bazedoxifene (Q46718995)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 July 2012

Language	Label	Description	Also known as
English	Relationships between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with bazedoxifene	scientific article published on 28 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

Relationships between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with bazedoxifene (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

Jean-Yves Reginster

4

object named as

Jean-Yves Reginster

1 reference

Europe PubMed Central

24 December 2017

Olivier Bruyère

1

object named as

Olivier Bruyère

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

author name string

Johann Detilleux

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

Arkadi Chines

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

language of work or name

0 references

publication date

28 July 2012

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

Calcified Tissue International

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

91

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

244-249

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

https://scigraph.springernature.com/pub.10.1007/s00223-012-9629-y

0 references

Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

A method to assess the proportion of treatment effect explained by a surrogate endpoint

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Compliance with osteoporosis medications

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Early changes in bone specific turnover markers during the healing process after vertebral fracture

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Biochemical markers of bone turnover are influenced by recently sustained fracture.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9629-Y

21 January 2018

Identifiers

10.1007/S00223-012-9629-Y

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/22945761

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46718995&oldid=2138424071"